Google and Character.AI Settle Lawsuits Over Teen Deaths Linked to Chatbot Relationships
Google and Character.AI settled five lawsuits, including the Sewell Setzer III wrongful-death case, alleging AI companion chatbots contributed to harm and death among teenagers.
MyFitnessPal’s New AI Nutrition Coach Arrives as Study Finds Calorie-Photo Apps Are Often Wrong by 345 Calories
MyFitnessPal launched an AI Nutrition Coach built on its Cal AI acquisition, just as a NUTRITION 2026 study found AI calorie-photo apps average a 345-calorie estimation error.
Apple Shelves AI Health Coach, Still Ships AI That Listens for Your Snoring
Apple delayed its AI health coach, Project Mulberry, at WWDC 2026 but is shipping AI sleep-sound detection and an Apple Watch Series 12 with 5-second heart-rate sampling.
Google Kills Fitbit Brand, Bets on $9.99/Month Gemini Health Coach
Google is retiring the Fitbit brand for a $9.99/month Gemini-powered Health Coach launching May 19, 2026, alongside a new $99.99 Fitbit Air tracker.
AI-Powered Depression Screening Tool Outperforms Standard Questionnaire, Chinese Study Finds
A Zhengzhou Normal University study found that a ChatGPT-based depression screening tool, BDI-FS-GPT, achieved 89.3% sensitivity, outperforming the widely used PHQ-9 questionnaire, though researchers caution larger trials are still needed.
Dartmouth’s Therabot Shows How a University-Built AI Chatbot Is Trying to Prove Itself Clinically
Dartmouth's Therabot, developed by psychiatry researchers Michael Heinz and Nicholas Jacobson, is being held up as an example of an AI mental health chatbot built and validated through clinical research rather than consumer trial and error.
Cytovale’s AI-Read Sepsis Test Cuts Mortality 19% Across Four More Hospitals, New Multicenter Data Show
New multicenter data presented at the Society of Critical Care Medicine's 2026 Critical Care Congress show Cytovale's AI-interpreted IntelliSep sepsis test cut mortality 19% across four expansion hospitals and more than 34,000 ED patients — though the results come from vendor-linked, pre-post analysis rather than an independent randomized trial.
Ono Pharmaceutical Partners With Aitia to Hunt Neurological Drug Targets Using Causal AI ‘Digital Twins’
Ono Pharmaceutical has partnered with Aitia to use causal AI 'digital twins' to identify new drug targets for hard-to-treat neurological diseases, joining a wave of 2026 pharma-AI deals betting that modeling cause and effect — not just correlation — can finally move the needle on brain disease drug discovery.
Oura’s New AI Model Aims to Answer the Women’s Health Questions Doctors Don’t Have Time For
Oura has built a proprietary AI model dedicated to women's health that blends clinician-vetted research with a user's own biometric data, aiming to give more trustworthy answers on cycles, pregnancy and menopause than generic search results.